# DAISY Uterine Drain Device Evaluation

> **NCT06219538** · NA · COMPLETED · sponsor: **Raydiant Oximetry, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Cesarean Section Complications
- Post Partum Hemorrhage
- Uterine Atony With Hemorrhage
- Uterine Bleeding

## Interventions

- **DEVICE:** DAISY Uterine Drain

## Key facts

- **NCT ID:** NCT06219538
- **Lead sponsor:** Raydiant Oximetry, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-22
- **Primary completion:** 2025-04-16
- **Final completion:** 2025-04-16
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06219538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06219538, "DAISY Uterine Drain Device Evaluation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06219538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*